Literature DB >> 11755155

Effects of wortmannin on airways inflammation induced by allergen in actively sensitised Brown Norway rats.

B Tigani1, J P Hannon, L Mazzoni, J R Fozard.   

Abstract

We have investigated the effect of wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase, on the immediate-type allergic response and the late phase pulmonary inflammation induced by allergen challenge in the ovalbumin-sensitised Brown Norway rat. Intratracheal (i.t.) instillation of ovalbumin induced dose-related bronchoconstrictor responses. Administration of wortmannin (1, 10 or 100 microg kg(-1) i.t., 1 h prior to challenge) induced a marked and dose-dependent inhibition of ovalbumin-induced bronchospasm (ED(50) ca. 5 microg kg(-1) i.t.). At similar doses, wortmannin also suppressed the bronchoconstrictor responses to 5-hydroxytryptamine and methacholine but the degree of blockade of these spasmogens (1.4-1.9-fold) was less than that of ovalbumin (>20-fold). Wortmannin, given intratracheally 1 h prior to allergen challenge, also suppressed the increases in bronchoalveolar lavage fluid leukocyte numbers and eosinophil peroxidase activity measured 24 h post challenge. However, relatively high doses were necessary (ED(50) ca. 100 microg kg(-1) i.t.). The potency of wortmannin was increased when dosed 1 h prior to and 24 h after allergen challenge and the readout was 48 h after challenge (ED(50) 3-5 microg kg(-1) i.t.). Thus, wortmannin is a potent inhibitor of the bronchoconstrictor response induced by allergen in the airways of actively sensitised Brown Norway rats. Inhibition of phosphatidylinositol-3-kinase, an obligatory step in mast cell activation in response to allergen, is the presumed mechanism of action. The fact that similar doses of wortmannin do not suppress the late response to allergen suggests a minimal role for the mast cell in generating the late response to allergen in this model. The striking increase in potency to inhibit the late response when dosed 1 h prior to and 24 h after allergen challenge with the readout taken at 48 h may represent an effect of wortmannin to suppress the migration of leukocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11755155     DOI: 10.1016/s0014-2999(01)01515-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond.

Authors:  David A Medina-Tato; Stephen G Ward; Malcolm L Watson
Journal:  Immunology       Date:  2007-08       Impact factor: 7.397

2.  Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma.

Authors:  Yong-Geun Kwak; Chang H Song; Ho K Yi; Pyoung H Hwang; Jong-Suk Kim; Kyung S Lee; Yong C Lee
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  In vivo pharmacological evaluation of compound 48/80-induced airways oedema by MRI.

Authors:  H Karmouty-Quintana; F-X Blé; C Cannet; S Zurbruegg; J R Fozard; C P Page; N Beckmann
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

4.  Inhibition of LPS-induced cyclooxygenase 2 and nitric oxide production by transduced PEP-1-PTEN fusion protein in Raw 264.7 macrophage cells.

Authors:  Sun Hwa Lee; Yeom Pyo Lee; So Young Kim; Min Seop Jeong; Min Jung Lee; Hye Won Kang; Hoon Jae Jeong; Dae Won Kim; Eun Joung Sohn; Sang Ho Jang; Yeon Hyang Kim; Hyung Joo Kwon; Sung Woo Cho; Jinseu Park; Won Sik Eum; Soo Young Choi
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

5.  p110γ/δ Double-Deficiency Induces Eosinophilia and IgE Production but Protects from OVA-Induced Airway Inflammation.

Authors:  Benedikt Mothes; Kirsten Bucher; Susanne Ammon-Treiber; Matthias Schwab; Roland P Piekorz; Emilio Hirsch; Bernd Nürnberg; Sandra Beer-Hammer
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.